$ATNM Actinium Pharmaceuticals, Inc. Insider Trading
Get free email notifications about insider trading in Actinium Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Actinium Pharmaceuticals, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Actinium Pharmaceuticals, Inc. for free.
CIK Number: 0001388320
IRS Number: 880378336
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: ATNM
Company Address: 275 MADISON AVENUE, 7TH FLOOR NEW YORK 10016
Phone number: (646)459-4201
Former name: Cactus Ventures, Inc., date of change: 2007-01-30
Prev close: $0.00
Average Daily Volume: 0
Days Low: $0.00
Year Low: $0.00
Year High: $0.00
Actinium Pharmaceuticals, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 14 2020 | ATNM | Actinium Pharmaceu ... | O'Loughlin Steve | Chief Financial Off ... | Option Exercise | A | 9.55 | 59,066 | 564,080 | 59,066 | |
Aug 14 2020 | ATNM | Actinium Pharmaceu ... | SETH SANDESH | Chief Executive Off ... | Option Exercise | A | 9.55 | 139,062 | 1,328,042 | 139,062 | |
Aug 14 2020 | ATNM | Actinium Pharmaceu ... | Chell Jeffrey W. | Director | Option Exercise | A | 9.55 | 8,333 | 79,580 | 8,333 | |
Aug 14 2020 | ATNM | Actinium Pharmaceu ... | Berger Mark Stanley | Chief Medical Offic ... | Option Exercise | A | 9.55 | 46,667 | 445,670 | 46,667 | |
Aug 14 2020 | ATNM | Actinium Pharmaceu ... | Steinhart Richard I | Director | Option Exercise | A | 9.55 | 8,333 | 79,580 | 8,333 | |
Aug 14 2020 | ATNM | Actinium Pharmaceu ... | Shetty Ajit | Director | Option Exercise | A | 9.55 | 8,333 | 79,580 | 8,333 | |
Aug 14 2020 | ATNM | Actinium Pharmaceu ... | Ludwig Dale L. | Chief Science & Tec ... | Option Exercise | A | 9.55 | 50,000 | 477,500 | 50,000 | |
Aug 14 2020 | ATNM | Actinium Pharmaceu ... | Nicholson, C. David | Director | Option Exercise | A | 9.55 | 8,333 | 79,580 | 8,333 | |
Jul 16 2019 | ATNM | Actinium Pharmaceu ... | Steinhart Richard I | Director | Option Exercise | A | 0.23 | 250,000 | 58,000 | 250,000 | |
Jul 16 2019 | ATNM | Actinium Pharmaceu ... | Chell Jeffrey W. | Director | Option Exercise | A | 0.23 | 250,000 | 58,000 | 250,000 | |
Jul 16 2019 | ATNM | Actinium Pharmaceu ... | Ludwig Dale L. | Chief Scientific Of ... | Option Exercise | A | 0.23 | 400,000 | 92,800 | 400,000 | |
Jul 16 2019 | ATNM | Actinium Pharmaceu ... | O'Loughlin Steve | Principal Financial ... | Option Exercise | A | 0.23 | 400,000 | 92,800 | 400,000 | |
Jul 16 2019 | ATNM | Actinium Pharmaceu ... | Berger Mark Stanley | Chief Medical Offic ... | Option Exercise | A | 0.23 | 400,000 | 92,800 | 400,000 | |
Jul 16 2019 | ATNM | Actinium Pharmaceu ... | SETH SANDESH | CEO | Option Exercise | A | 0.23 | 1,500,000 | 348,000 | 1,500,000 | |
Jul 16 2019 | ATNM | Actinium Pharmaceu ... | Kapur Anil | Chief Commercial Of ... | Option Exercise | A | 0.23 | 400,000 | 92,800 | 400,000 |
View all Actinium Pharmaceuticals, Inc. insider transactions.